Clinical and laboratory studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in bronchopulmonary diseases.
D000284:Administration, Oral; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D005334:Fever / Q000188:drug therapy; D006207:Half-Life; D006801:Humans; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D011485:Protein Binding; D011720:Pyrazoles / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D013488:Suppositories; D013729:Terpenes / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D013488:Suppositories; D013729:Terpenes